Holistic developer program provides deep
technology integration in a secure platform; flexibly deploys in
the cloud, at the edge or on device
New Edison-powered smart devices and
intelligent applications simplify workflows, drive efficiency and
improve clinical outcomes
GE Healthcare today launched the Edison Developer Program to
accelerate the adoption and impact of intelligent applications and
developer services across health systems. The program is based on
Edison, GE Healthcare’s secure intelligence platform, and helps
healthcare providers gain easier access to market-ready algorithms
and applications by directly integrating these technologies into
existing workflows.
For developers, the Edison Developer Program offers a rich set
of healthcare services to help accelerate their ability to build
innovations that improve operational and clinical outcomes – and
also gives them access to scale and the ability to deploy
applications across GE Healthcare’s massive customer base. This
program expands the existing Edison ecosystem of leading
researchers, technology providers and academic institutions who
develop, manage, secure and distribute advanced applications,
services and AI algorithms to drive real healthcare outcomes.
GE Healthcare also unveiled several new, Edison-powered
technologies, including smart devices and intelligent applications,
across a variety of clinical areas. These new solutions are
designed to make data, insights and clinical context more
accessible and actionable across the health system, creating new
value for providers and patients — from reducing costs and
complexity to increasing the speed and accuracy of diagnosis.
“We introduced Edison just one year ago at RSNA to help health
providers take advantage of data in new and significant ways,” said
Kieran Murphy, President and CEO, GE Healthcare. “With the
introduction of the Edison Developer Program, and a suite of new
intelligent applications and smart devices powered by Edison, we
are building on that promise as we continue to work with partners
to realize our collective goal of advancing the future of
health.”
New Edison Developer Program to Accelerate AI Integration,
Advance Outcomes
Investment in healthcare startups is exploding1 – but
implementing new innovations effectively can be cumbersome and
complex, slowing adoption. For instance, deploying a one-off
clinical AI application is currently a manual and disjointed
process. Clinicians are looking for a single solution that can span
multiple modalities and seamlessly integrate applications or AI
algorithms directly into their existing workflows to harness the
power of these technologies.2
The Edison Developer Program addresses these needs directly by
bringing market-ready AI applications to the Edison platform,
integrating them into existing GE Healthcare offerings – on medical
devices, in the cloud or at the edge of the network. This deep
integration makes it easier for AI and analytics innovators to
build, deploy and distribute their offerings. It breaks down
barriers to adoption for clinicians, ultimately reducing costs and
improving the value of new solutions.
GE Healthcare is actively working with a range of AI and
analytics innovators – such as Arterys, iCAD, Koios Medical, MaxQ
AI and Volpara – to deliver outcomes for healthcare systems via
Edison. For example, Koios Medical built and deployed Breast
Assistant, powered by Koios™ DS, an embedded application designed
to automatically provide an AI-based quantitative risk assessment
that aligns to a BI-RADS category, delivering results in two
seconds or less and providing decision support for the clinician.
Together, Koios and GE Healthcare integrated their solution into
the LOGIQ E10 ultrasound system. Also as part of the Edison
Developer Program, GE Healthcare recently launched two initiatives
in India and China aimed at growing the regional ecosystem and
accelerating availability of local solutions.
“The opportunities for healthcare with a truly intelligent
connected digital enterprise are significant, but no one
organization can get there alone,” said Amit Phadnis, Chief Digital
Officer, GE Healthcare. “The Edison Developer Program is unique in
its deep technology integration and scaling through the workflow,
opening the door to faster adoption by health systems. Bringing
together leading technology providers, developers and academic
institutions under a single, connected ecosystem will help our
customers simplify and optimize data aggregation and orchestration
of clinical and operational applications in ways that have the
potential to create real impact from the bottom line to better
patient outcomes.”
The Edison Developer Program exposes a number of potential
capabilities of the Edison platform, including secure device
connectivity, data aggregation for clinical context, advanced
visualization, workflow and AI orchestration, in addition to a rich
set of AI capabilities for data traceability, curation, annotation,
model training and inferencing. This set of services will reduce
the complexity of developing and integrating AI and data-based
healthcare applications in clinical workflows. Program members are
selected and vetted based on rigorous clinical and technical
evaluations as well as regulatory clearance to ensure confidence
and security of solutions offered through the Edison platform.
Expanded Partner Network to Extend Rapidly Growing Edison
Ecosystem
These AI and analytics startups add to a rapidly growing Edison
ecosystem of prominent academic institutions, technology providers
and medtech companies, including:
- Partners HealthCare and GE Healthcare are working
together to improve the patient journey through co-development and
integration of deep learning technology across the entire continuum
of care under the Massachusetts General Hospital and Brigham and
Women’s Hospital Center for Clinical Data Science. The
collaboration currently includes 15 active projects underway within
areas such as Women’s Health, Cardiology, Oncology, Hospital
Operations and Emergency Medicine, and relevant imaging modalities
such as Computed Tomography (CT), Magnetic Resonance (MR) and
Ultrasound (US).
- The Saint-Joseph Hospital Foundation in Paris and GE
Healthcare are creating a research and development laboratory
designed to further the benefits of digital technologies across the
healthcare journey, including the use of data and AI to optimize
operating theatres and monitor the impact of contrast media.
- Intel and GE Healthcare have integrated the open source
Intel Distribution of OpenVINO toolkit software in the Edison
platform for inference acceleration across modalities from edge to
cloud. This has resulted in breakthrough performance in Artificial
Intelligence Prescription (AIR x), an automated workflow tool
designed to accelerate and optimize MR brain scanning, and the
Critical Care Suite pneumothorax detection algorithm running on GE
Healthcare’s Optima* XR240amx mobile X-ray system, all powered by
Intel processors.
New Edison Devices, Applications to Improve Efficiencies,
Clinical Diagnosis
Additionally, GE Healthcare unveiled a number of new
Edison-powered smart devices and intelligent applications designed
to help healthcare providers simplify workflows and increase
efficiencies while also improving patient comfort and advancing
clinical outcomes. These offerings bring together GE Healthcare’s
unique capabilities across both imaging devices and software to
help health systems more quickly and seamlessly deploy technologies
across their care environments.
- Edison Open AI Orchestrator: Designed to orchestrate AI
at scale for imaging workflows, the new Edison Open AI Orchestrator
simplifies the implementation, deployment, support and scaling of
multiple AI applications including from partners iCAD and MaxQ AI.
Designed to seamlessly integrate clinical applications into the
radiology PACS reading workflow, this offering reduces the
complexity of multiple systems and algorithms working together that
could lead to error and risk if implemented incorrectly.
- LOGIQ E10: This next-generation radiology ultrasound
system integrates AI, advanced tools and enhanced workflow
capabilities to enable clinicians to scan, diagnose and treat a
wide range of patients across a broad spectrum of conditions. One
of its newest applications, Breast Assistant, powered by Koios DS,
automatically provides an AI-based quantitative risk assessment
that aligns to a BI-RADS category. The results are available in two
seconds or less, providing decision support for the clinician and
helping improve consistency across the department.
- New Revolution family CT scanner: This powerful, high
performing and reliable CT simplifies every step of the CT
workflow. Powered by AI, the new Revolution family CT scanner uses
real-time depth sensing technology to generate a 3D model of a
patient’s body to pinpoint the center of the scan range and
automatically align it to the isocenter of the bore. Altogether, it
is designed to simplify, streamline and automate the entire CT
experience.
- AIR x: An Edison application, this AI-based, automated
workflow tool for MRI brain scanning increases consistency and
productivity by providing automated slice prescriptions to help
reduce previously redundant, manual steps. AIR x produces images
that have less variability between technologists and between scans,
to lower the chances for a patient to be recalled due to incorrect
slice placement. An increase in consistency is particularly
important when doing longitudinal assessments for diseases like
Alzheimer’s and Multiple Sclerosis. Technologists can set up exams
five times faster and perform four times fewer mouse clicks using
deep learning with AIR x.
The Edison platform helps GE Healthcare and select strategic
partners design, develop, manage, secure and distribute
applications and AI algorithms quickly. These new Edison-enabled
devices and applications support GE Healthcare’s goal of advancing
the future of health and continue the growing strength of the
Edison ecosystem. Additional details can be found at here and at
RSNA in GE Healthcare’s booth in the South Hall #4133 or in the AI
Showcase Level 1 North #10905.
*510(k) pending at FDA. Not available for sale in the United
States.
Note: Edison, Revolution CT, AIRx, LOGIQ are trademarks of
General Electric Company.
About GE Healthcare:
GE Healthcare is the $19.8 billion healthcare business of GE
(NYSE: GE). As a leading provider of medical imaging, monitoring,
biomanufacturing, and cell and gene therapy technologies, GE
Healthcare enables precision health in diagnostics, therapeutics
and monitoring through intelligent devices, data analytics,
applications and services. With over 100 years of experience in the
healthcare industry and more than 50,000 employees globally, the
company helps improve outcomes more efficiently for patients,
healthcare providers, researchers and life sciences companies
around the world.
Follow us on Facebook, LinkedIn, Twitter and Insights for the
latest news, or visit our website www.gehealthcare.com for more
information.
1 Signify Funding Analysis of Companies Developing Machine
Learning Solutions for Medical Imaging Jan 31,2019
2 Quantitative Market Research, MarketVision Research, PACS AI,
VNA AI, and AI Workflow, 2019; AI Clinical Apps Research
Quantitative Market Research, MarketVision Research, MVR Project:
18-0473, 2018.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191126005287/en/
Amy Sarosiek amy.sarosiek@ge.com +1 224.239.6028
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Mar 2024 to Apr 2024
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2023 to Apr 2024